National Academy of Sciences of Belarus   Report issue

Academic/Hospital Phase 2
Founded: Belarus Belarus (1929)

Organization Overview

First Clinical Trial
2009
NCT04457037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ass prof of 2nd Department of Surgical Diseases of BSMU | Director, the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 2)

Chronic Periodontitis (Phase 2)

Corneal Diseases (Phase 2)

Corneal Ulcer (Phase 2)

Endometritis (Phase 2)

Enuresis (Phase 2)

Gingival Recession (Phase 2)

Gynatresia (Phase 2)

Lung Diseases, Interstitial (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Periodontitis (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Ulcer (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urinary Incontinence (Phase 2)

Urinary Incontinence, Stress (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 16
  • # of Trial APIs: 10